| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Nichols William Garrett is a Chief Medical Officer at Candel Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $438K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2025 | CADL Candel Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 937 | $6.98 | $6,540.26 | -1.8% | -21.3% | - | |
| Jun 30, 2025 | CADL Candel Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 781 | $5.04 | $3,936.24 | -1.5% | +6.7% | - | |
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 45,316 | $8.76 | $396,995.35 | -46.3% | -41.5% | -42.9% | |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | Chief Medical Officer | Sell | 10,428 | $7.23 | $75,342.30 | -11.6% | -38.1% | -25.7% | |
| Jan 8, 2025 | CADL Candel Therapeutics, Inc. | Chief Medical Officer | Sell | 10,799 | $8.22 | $88,749.42 | -10.7% | -49.7% | -36.4% | |
| Nov 29, 2024 | CADL Candel Therapeutics, Inc. | Chief Medical Officer | Sell | 13,935 | $4.56 | $63,482.29 | -12.2% | +82.8% | +1.4% | |
| Jul 17, 2024 | CADL Candel Therapeutics, Inc. | Chief Medical Officer | Sell | 10,875 | $6.47 | $70,389.53 | -8.7% | -9.4% | +5.3% | |
| Jul 11, 2024 | CADL Candel Therapeutics, Inc. | Chief Medical Officer | Sell | 9,769 | $5.97 | $58,354.14 | -7.2% | +1.4% | -1.7% |